IO
IOFNF.US Iofina plc
- Market cap
- USD 121M
- P/E
- 12.6x
- P/B
- 2.04x
- ROE
- 23.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is IOFNF.US undervalued?
Graham numberIOFNF.US trades 6.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Iofina plc fundamental analysis
No fundamental analysis for Iofina plc yet.
Iofina plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Iofina plc
Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, mineral separators, specialty intermediates, thyroid health, wound healing, diagnostic imaging, io…
Full company profileIofina plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Iofina plc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 22.5M | 20.8M | 24.0M | 29.2M | 29.7M | 39.0M | 42.2M | 50.0M | 54.5M | 68.0M | 124M |
| Gross Profit | 2.70M | 4.86M | 6.31M | 8.25M | 8.41M | 10.7M | 15.8M | 15.7M | 13.2M | 15.2M | 33.4M |
| Operating Income | -3.32M | -680K | 1.07M | 2.81M | 2.93M | 5.21M | 9.64M | 8.59M | 4.96M | 8.88M | 19.3M |
| EBITDA | 367K | -4.95M | 1.99M | 4.64M | 4.72M | 7.13M | 12.0M | 10.7M | 7.65M | 12.1M | 26.2M |
| Net Income | -3.66M | -9.74M | -1.14M | 552K | 1.28M | 9.19M | 7.87M | 6.56M | 2.92M | 8.04M | 13.8M |
| EPS | -0.03 | -0.08 | -0.01 | 0.00 | 0.01 | 0.05 | 0.04 | 0.03 | 0.01 | 0.04 | 0.07 |
| Balance Sheet | |||||||||||
| Total Assets | 40.6M | 36.8M | 36.1M | 43.7M | 39.8M | 44.4M | 52.7M | 60.5M | 63.8M | 79.3M | 83.5M |
| Total Liabilities | 23.9M | 29.8M | 30.2M | 24.5M | 19.2M | 14.5M | 14.7M | 15.8M | 16.0M | 23.6M | 24.4M |
| Shareholders' Equity | 16.7M | 6.97M | 5.95M | 19.2M | 20.7M | 30.0M | 38.0M | 44.8M | 47.8M | 55.8M | 59.1M |
| Cash & Short-term Investments | 2.82M | 3.45M | 4.52M | 9.62M | 4.38M | 5.26M | 5.93M | 6.52M | 6.86M | 11.7M | 12.9M |
| Total Debt | 16.0M | 21.8M | 24.8M | 18.5M | 12.6M | 8.68M | 7.20M | 5.84M | 4.26M | 6.67M | 6.39M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 451K | -264K | 1.99M | 3.35M | 3.78M | 7.89M | 5.55M | 8.57M | 11.5M | 11.1M | 30.9M |
| Capital Expenditure | 670K | 2.08M | 908K | 1.70M | 2.45M | 1.49M | 3.09M | 6.23M | 9.51M | 8.57M | 22.7M |
| Free Cash Flow | -219K | -2.35M | 1.08M | 1.66M | 1.33M | 6.41M | 2.46M | 2.34M | 2.02M | 2.55M | 8.23M |
| Ratios | |||||||||||
| ROE | -21.9% | -139.8% | -19.2% | 2.9% | 6.2% | 30.7% | 20.7% | 14.7% | 6.1% | 14.4% | 23.3% |
| ROA | -9.0% | -26.5% | -3.2% | 1.3% | 3.2% | 20.7% | 14.9% | 10.8% | 4.6% | 10.1% | 16.5% |
| Net Profit Margin | -16.3% | -46.7% | -4.8% | 1.9% | 4.3% | 23.5% | 18.6% | 13.1% | 5.4% | 11.8% | 11.1% |
| Debt to Equity | 0.96x | 3.12x | 4.17x | 0.96x | 0.61x | 0.29x | 0.19x | 0.13x | 0.09x | 0.12x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Iofina plc dividends
Iofina plc has not paid dividends in the last 9 fiscal years.
Last stock split: 253:250 on May 20, 2019.
Who owns Iofina plc
- Insiders 42.47%
- Institutions 6.95%
- Public & others 50.59%
- Shares outstanding 192M
- Free float 103M
Iofina plc company profile
- Company name
- Iofina plc
- Ticker
- IOFNF.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 126
- Fiscal year end
- December
- Address
- 48 Chancery Lane, London, United Kingdom, WC2A 1JF
- Phone
- 44 20 3006 3135
- Website
- iofina.com
About Iofina plc
Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, mineral separators, specialty intermediates, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etchant gas, soil fumigants, fine halogen chemicals, electronic specialty gases, and heat stabilizers applications. The company markets its products in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, nylon, x-ray contrast media industries. It serves animal nutrition, biocidal paints and coatings, disinfectants, x-ray contrast media, pharmaceuticals, electronics, perovskites for solar, optical polarizing films, industrial, oil and gas industries. The company sells its products under the IOflo and IOprill brand names. Iofina plc was incorporated in 2005 and is based in London, the United Kingdom.
Iofina plc management
5- Dr. Thomas Matthew BeckerCEO, President & Executive Director · born 1969
- Mr. Malcolm Thomas Lewin FCACFO & Executive Director · born 1951
- Mr. Forest Dale DornChief Operating Officer of Iofina Resources Inc · born 1955
- Mr. Kurt JonesChief Operating Officer of Iofina Chemical Inc
- Mr. Simon William Holden Esq.Company Secretary · born 1976